对评分系统进行比较分析,以预测紧急拉皮切除术中的发病率和死亡率
Shreyas Srinivasan1, Cherring Tandup1, Arunanshu Behera1
1Department of General Surgery, PGIMER, Chandigarh, India.
ANZ journal of surgery
|October 23, 2025
概括
国家紧急腹腔切除术审计 (NELA) 评分最好预测紧急腹腔切除术后的死亡率. 哈吉班德赫指数在预测外科手术部位感染和位泄漏方面优越,而P-POSSUM在重新探索风险方面提供了更高的特异性.
科学领域:
- 手术成果研究的研究结果.
- 临床风险分层化临床风险分层化
- 紧急医疗 紧急医疗
背景情况:
- 紧急腹腔切除术具有严重的发病和死亡风险.
- 有几种工具用于风险分层,包括NELA,P-POSSUM,ACS-NSQIP和Hajibandeh指数.
- 对这些工具的比较分析对于优化患者护理至关重要.
研究的目的:
- 为了比较NELA,P-POSSUM,ACS-NSQIP和Hajibandeh指数的预测准确度.
- 评估这些评分系统在紧急腹腔切除术后预测死亡率和关键术后发病率方面的表现.
主要方法:
- 一项前性观察性研究包括510名接受紧急腹腔切除术的患者.
- 进行了手术前风险评估,使用NELA,P-POSSUM,ACS-NSQIP和Hajibandeh指数.
- 评估的结果包括30天死亡率,手术部位感染,静脉泄漏和重新探索,评估诊断准确性.
主要成果:
- 尼拉评分显示了30天死亡率的最高预测准确度 (C统计:0.979).
- 哈吉班德赫指数显示了预测手术部位感染 (C-统计:0.760) 和静脉漏 (C-统计:0.741) 的最高灵敏度.
- P-POSSUM在预测重新勘探方面表现出最大的特异性.
结论:
- 尼拉评分是紧急腹腔切除术中死亡率的最可靠预测指标.
- 哈吉班德赫指数是有效的预测术后发病率,如SSI和动脉漏.
- 对于重新探索风险,P-POSSUM提供了卓越的特异性,这表明这些工具的联合使用可以提高患者风险评估和结果.
更多相关视频
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
485
09:00Application of Straight-needle, Three-tailed, Knot-free, Peritoneal Sutures in Laparoscopic Transabdominal Preperitoneal Hernia Repair
Published on: November 12, 2021
2.3K
相关概念视频
Comparing the Survival Analysis of Two or More Groups
551
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
551
Kaplan-Meier Approach
566
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
566
